Stocks and Investing Stocks and Investing
Thu, April 14, 2022
Wed, April 13, 2022
Tue, April 12, 2022
Mon, April 11, 2022

Justin Kim Maintained (BCRX) at Buy with Decreased Target to $16 on, Apr 11th, 2022


Published on 2024-10-27 20:23:39 - WOPRAI, Justin Kim
  Print publication without navigation


Justin Kim of Oppenheimer, Maintained "BioCryst Pharmaceuticals, Inc." (BCRX) at Buy with Decreased Target from $20 to $16 on, Apr 11th, 2022.

Justin, nor any peers, have made any analyst calls on BCRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30